Literature DB >> 7639418

The effect of ageing on platelet function and fibrinolytic activity.

G Gleerup1, K Winther.   

Abstract

Twelve healthy male volunteers, mean age twenty-five, range twenty-one to thirty years, and 12 healthy middle-aged male volunteers mean age fifty-eight, range forty-four to seventy-two years, were tested regarding platelet aggregation induced by adenosine diphosphate and fibrinolytic activity, estimated as euglobulin clot lysis time (ECLT), tissue plasminogen activator (t-PA), and the fast-acting inhibitor against t-PA normally referred to as (PAI-1). Platelet aggregation increased significantly in the middle-aged group as compared with the young, as shown by a decrease in ADP thresholds for irreversible aggregation (P < 0.01). In healthy young volunteers, vigorous cycling exercise by itself caused platelet aggregability to decrease (P < 0.05). Such changes were not observed in the elderly. Fibrinolytic activity decreased significantly in the middle-aged group as shown by a prolongation of the ECLT (P < 0.01) and PAI-1, although not significantly, increased by approximately 100%, whereas t-PA significantly increased in the middle-aged group (P < 0.01). The present results suggest that increasing age is associated with not only increased platelet aggregability but also decreased fibrinolytic activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7639418     DOI: 10.1177/000331979504600810

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  24 in total

1.  Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats.

Authors:  D G Hemmings; Y Xu; S T Davidge
Journal:  Br J Pharmacol       Date:  2004-08-23       Impact factor: 8.739

Review 2.  Risk factors for venous and arterial thrombosis.

Authors:  Emanuele Previtali; Paolo Bucciarelli; Serena M Passamonti; Ida Martinelli
Journal:  Blood Transfus       Date:  2010-10-25       Impact factor: 3.443

Review 3.  Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.

Authors:  Matteo Cesari; Marco Pahor; Raffaele Antonelli Incalzi
Journal:  Cardiovasc Ther       Date:  2010-07-07       Impact factor: 3.023

Review 4.  Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation.

Authors:  M S el-Sayed
Journal:  Sports Med       Date:  1996-11       Impact factor: 11.136

5.  Intra-arterial thrombolysis for acute stroke in patients 80 and older: a comparison of results in patients younger than 80 years.

Authors:  D Kim; G A Ford; C S Kidwell; S Starkman; F Vinuela; G R Duckwiler; R Jahan; J L Saver
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

6.  Adenosine and blood platelets.

Authors:  Hillary A Johnston-Cox; Katya Ravid
Journal:  Purinergic Signal       Date:  2011-02-08       Impact factor: 3.765

7.  Age and aerobic training status effects on plasma and skeletal muscle tPA and PAI-1.

Authors:  Ryan M Francis; Christine L Romeyn; Adam M Coughlin; Paul R Nagelkirk; Christopher J Womack; Jeffrey T Lemmer
Journal:  Eur J Appl Physiol       Date:  2014-03-07       Impact factor: 3.078

8.  Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization.

Authors:  Carson K Lam; Taehwan Yoo; Bennett Hiner; Zhiqiang Liu; Jaime Grutzendler
Journal:  Nature       Date:  2010-05-27       Impact factor: 49.962

Review 9.  Aspirin for the prevention of cardiovascular events in the elderly.

Authors:  Isabelle Mahé; Alain Leizorovicz; Charles Caulin; Jean-François Bergmann
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 10.  Modulators of platelet function in aging.

Authors:  Krishna S Iyer; Sanjana Dayal
Journal:  Platelets       Date:  2019-09-16       Impact factor: 3.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.